LUMA Vision Announces $22 Million in New Financing to Secure FDA Approval and Advance Development of 4D Cardiac Imaging and Navigation Platform

Contributed by: Business Wire

Logo

Images

LUMA Vision Co-Founders, CEO Fionn Lahart (right) and Chief Technology Officer Christoph Hennersperger (left). (Photo: Business Wire)

Business Wire embedded0

Tags

Medical Devices

Health

Technology

Health Technology

Software

Cardiology

$22 Million

More Like This

PR Newswire associated0

LUMA Vision Receives FDA Clearance for VERAFEYE 2D/4D Cardiac Visualization Platform

PR Newswire associated0

LUMA Vision Successfully Completes First-in-Human Procedures with its Novel VERAFEYE™ Navigation and Visualization Platform

Caldera Medical Acquires UVision360 and the LUMINELLE Product Family, Expanding Minimally Invasive Hysteroscopy Portfolio

MedLumics New CEO and Board Member Announces 10 Patients Treated in First in Man (FIM) Clinical Trial With the Real-Time Visually Guided AblaView PFA System

LumiThera Obtains FDA Authorization of Valeda Treatment for Dry AMD Patients to Improve Vision

PR Newswire associated0

CardiaCare Completes Seed Extension Raise to Support Clinical Pilot Studies

LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Roche

Robert Dempsey, Chairman of the Board, Azalea Vision

Azalea Vision Raises €9 Million in First Closing of Series A to Further Develop Intelligent Connected Vision Platform